AI investing is often described through the companies that build models, chips, or data centers. Those layers matter, but they are not the end market. The economic payoff appears when AI is embedded in the software, workflows, and products that people use to make decisions, complete tasks, and serve customers.
This article is Post 7 in our eight-part AI investment series. The series anchor overview in Articles and News explains the full value chain. Within that structure, the progression is AI Intelligence → AI Applications → Physical AI. This article focuses on AI Applications: enterprise software, health care, financial services, advertising, and consumer products that place AI directly in front of end users.
The distinction is important. AI Applications are the layer most directly connected to economic output, but they are also where investors must determine whether a product creates durable value or simply adds a temporary feature.
Why Applications Are the Payoff Layer
The application layer converts technical capability into measurable business outcomes. It is where organizations can potentially use AI to:
- Increase employee productivity
- Automate repetitive administrative work
- Improve customer acquisition and retention
- Reduce fraud, errors, and operating costs
- Accelerate research and product development
- Improve pricing, underwriting, and other decisions
- Create new services that were previously impractical
This layer touches the economy more directly than any other part of the AI value chain. A model may be technically impressive, but its investment relevance ultimately depends on whether customers pay for it, use it repeatedly, and achieve a return that exceeds implementation and infrastructure costs.
The most attractive applications generally have three characteristics:
- They are integrated into an existing workflow.
AI is more valuable when it operates inside a customer relationship management system, electronic health record, underwriting platform, advertising exchange, or productivity suite. - They use proprietary or difficult-to-replicate data.
Context from transaction histories, clinical records, business processes, or customer behavior can improve performance and create switching costs. - They produce measurable outcomes.
Revenue uplift, reduced claims expense, faster documentation, lower fraud losses, or improved employee throughput are stronger indicators than an AI label.
This is the central investment question: Does AI improve the economics of the application, or is it merely being added to maintain competitive parity?
Demand Drivers Across the Application Layer
Enterprise Software
AI is being embedded into productivity suites, customer relationship management, enterprise resource planning, cybersecurity, developer tools, and back-office systems. Common applications include:
- Drafting and summarizing documents, emails, and meetings
- Generating and testing software code
- Recommending sales actions and automating customer records
- Processing invoices and reconciling accounts
- Forecasting demand and managing inventory
- Detecting cybersecurity threats
- Coordinating multistep workflows through software agents
The commercial model is still developing. Vendors may charge separately for AI copilots, include AI within premium tiers, or use AI to increase retention and pricing power across an existing platform.
Large software companies such as Microsoft, Salesforce, ServiceNow, Adobe, and Oracle are representative examples of incumbents embedding AI into established products. AI-native companies may compete by offering specialized tools for legal services, logistics, financial analysis, customer support, or software development.
The economic test is not whether a product can generate a summary or answer a question. It is whether customers expand usage, reduce labor requirements, complete work faster, or become less likely to switch platforms.
Health Care
Health care applications span both clinical and administrative workflows. Examples include:
- Drug discovery and clinical-trial design
- Medical imaging and diagnostic assistance
- Clinical documentation and ambient transcription
- Patient scheduling and triage
- Prior authorization and revenue-cycle management
- Claims processing and fraud detection
- Remote patient monitoring and predictive analytics
Clinical documentation is an especially clear example of point-of-use adoption. AI-enabled tools can listen to a patient encounter and prepare a draft note for clinician review. The potential value is not the transcript itself. It is the time saved, the quality of the record, and the possibility of reducing administrative burden.
In drug discovery, the investment case is longer term and more uncertain. AI may improve target identification, molecule design, or trial recruitment, but development timelines, clinical validation, and regulatory approval remain decisive constraints. A better model does not eliminate the biological and commercial risks of bringing a therapy to market.
Health care also demonstrates why application-layer investing requires regulatory discipline. As noted in analyses from the Boston Consulting Group and the American Hospital Association, adoption depends on workflow integration, data quality, clinician trust, safety monitoring, and accountability: not simply model performance.
Financial Services
Financial institutions have used quantitative models for decades. Newer AI tools expand the scope and speed of those systems across:
- Real-time fraud detection
- Anti-money-laundering surveillance
- Credit underwriting and risk assessment
- Insurance claims and pricing
- Customer service and call-center automation
- Research summarization and portfolio analytics
- Personalized financial guidance and product recommendations
The strongest applications are often invisible to consumers. A model that prevents a fraudulent transaction or improves a claims review may create significant economic value without appearing as a standalone AI product.
Financial services also impose a high standard of governance. Models used in lending, insurance, or advice must be evaluated for accuracy, fairness, explainability, data security, and compliance. A model that performs well on average can still create unacceptable outcomes for specific customer groups or during stressed market conditions.
Advertising and Marketing
Advertising platforms apply AI to both targeting and creative production. Systems can optimize bids, identify likely customers, generate multiple versions of an advertisement, and measure engagement across channels.
The opportunity is substantial because advertising is already a data-intensive, software-mediated industry. AI can improve the allocation of marketing budgets and reduce the time required to produce and test creative assets.
The risk is that these capabilities may become standard features rather than durable sources of excess returns. If every major advertising platform offers similar targeting and creative tools, the advantage may accrue primarily to platforms with the largest audiences, highest-quality data, and strongest distribution.
Consumer Applications
Consumer AI includes assistants, search, education, health and wellness, shopping, entertainment, content creation, and personal productivity. The most successful products will need to become part of a repeated habit rather than a novelty.
Potential use cases include:
- Personalized search and recommendations
- Travel planning and shopping assistance
- Education and adaptive tutoring
- Content creation and editing
- Health and wellness support
- Voice-controlled household and mobile services
- AI-enabled gaming and entertainment
Consumer products face a particularly demanding standard: users may experiment with many tools but pay for very few. Distribution, trust, privacy, latency, and ease of use can matter as much as technical performance.
Where Investors May Find Opportunity
The application layer offers several distinct investment categories:
- Incumbent software leaders: Companies with established distribution can add AI to products already used daily by businesses.
- AI-native software companies: New entrants may redesign workflows rather than simply add a feature to an existing product.
- Mega-cap platforms: Large technology companies can monetize AI through advertising, cloud services, search, commerce, and productivity ecosystems.
- Health care beneficiaries: Providers of clinical documentation, imaging, drug discovery, administrative automation, and data infrastructure may benefit from adoption.
- Financial-services beneficiaries: Payment networks, fraud-prevention providers, insurers, banks, and financial technology companies may use AI to improve risk management and operating efficiency.
- Diversified funds: Sector funds and technology-oriented ETFs may provide exposure to multiple application companies, although investors must examine holdings carefully for concentration and valuation risk.
Representative public companies and ETFs can be useful for understanding the landscape. They are not recommendations. An investor should evaluate revenue growth, recurring usage, gross margins, customer retention, capital intensity, balance-sheet strength, valuation, and the durability of competitive advantages before making an allocation.
A critical portfolio issue is double-counting AI exposure. An investor may own a semiconductor manufacturer, a cloud provider, a software company, an advertising platform, and an ETF that holds all of them. These positions may appear diversified by industry label while remaining economically dependent on the same AI spending cycle. Mapping exposures across the entire value chain is necessary to understand actual concentration.
Principal Risks
Feature commoditization
AI capabilities can spread rapidly. A feature that supports premium pricing today may be included for free by competitors tomorrow. Durable value requires more than access to a large language model. It requires proprietary data, workflow integration, distribution, trust, or a cost advantage.
Implementation and adoption risk
Organizations may purchase AI tools without achieving meaningful productivity gains. Data cleansing, employee training, cybersecurity controls, system integration, and human review can materially reduce the expected return on investment.
Regulatory scrutiny
Health care and financial services face heightened oversight because AI can affect clinical decisions, access to credit, insurance pricing, and customer outcomes. Advertising and consumer applications face additional privacy, consumer-protection, and content-governance concerns.
Competitive disruption
AI-native companies may attack incumbent software vendors with simpler or more efficient products. At the same time, incumbents can use distribution, capital, customer relationships, and proprietary data to challenge startups. Market leadership is not guaranteed by either business model.
Margin uncertainty
AI can increase revenue while also increasing infrastructure, data, support, and compliance costs. Investors should distinguish gross-margin improvement from growth that requires disproportionate spending on compute and implementation.
Near-Term Results Versus Long-Term Potential
The long-term case for AI Applications is based on secular adoption across the economy. Businesses will continue searching for ways to automate routine work, improve decisions, and make services more responsive.
Near-term results will be uneven. Some companies will demonstrate measurable usage and revenue expansion. Others will announce ambitious AI strategies without producing sustained margin improvement. The differentiator will be evidence:
- Are customers actively using the product?
- Is usage expanding after the initial trial?
- Does the product improve retention or pricing?
- Can the company report measurable productivity or revenue gains?
- Are margins improving after accounting for AI-related costs?
- Does the company maintain appropriate controls and oversight?
AI branding is not a substitute for operating performance.
Portfolio Relevance
AI Applications represent the point where the technology value chain meets the broader economy. They can create meaningful opportunities across software, health care, financial services, advertising, and consumer products, but the investment case depends on adoption, economics, and competitive durability.
For investors, the appropriate analysis extends beyond identifying companies associated with AI. It requires examining how each holding is exposed to the full value chain, whether multiple positions depend on the same spending trend, and whether the expected benefit is reflected in the current valuation.
That analysis fits naturally within comprehensive financial planning and investment management. A disciplined portfolio review should consider concentration, liquidity, tax consequences, time horizon, risk capacity, and the role each investment plays in the broader plan.
The next layer is Physical AI, where intelligent systems interact with machines, robotics, industrial equipment, and the physical world. Until then, the application layer remains the most direct test of whether AI capability is becoming durable economic value.
Category: Articles and News
Tag: AI
Disclosure: This article is provided for general educational and informational purposes and does not constitute investment, tax, legal, or accounting advice. References to companies, securities, sectors, technologies, or exchange-traded funds are illustrative only and do not constitute a recommendation, solicitation, or offer to buy or sell any security. Investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. AI-related investments may be subject to significant volatility, valuation risk, regulatory risk, technological risk, and concentration risk. Investors should consult with qualified professionals and evaluate any investment in the context of their objectives, risk tolerance, time horizon, tax situation, and complete financial plan. InSight Financial Planners is a Registered Investment Adviser. Investment advisory services are offered through InSight Financial Planners and are subject to the terms of the applicable advisory agreement and disclosures.
